These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 19041685)

  • 61. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Galanti G; Fisher T; Kventsel I; Shoham J; Gallily R; Mechoulam R; Lavie G; Amariglio N; Rechavi G; Toren A
    Acta Oncol; 2008; 47(6):1062-70. PubMed ID: 17934890
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Celecoxib toxicity is cell cycle phase specific.
    Bock JM; Menon SG; Sinclair LL; Bedford NS; Goswami PC; Domann FE; Trask DK
    Cancer Res; 2007 Apr; 67(8):3801-8. PubMed ID: 17440094
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1).
    Huang J; Yang G; Huang Y; Kong W; Zhang S
    Mol Med Rep; 2016 Feb; 13(2):1373-80. PubMed ID: 26676829
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma.
    Heider U; Rademacher J; Lamottke B; Mieth M; Moebs M; von Metzler I; Assaf C; Sezer O
    Eur J Haematol; 2009 Jun; 82(6):440-9. PubMed ID: 19220424
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
    Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
    Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
    Graves TG; Harr MW; Crawford EL; Willey JC
    Mol Cancer; 2006 Jan; 5():1. PubMed ID: 16403226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.
    Choi EJ; Kim GH
    J Nutr Biochem; 2009 Apr; 20(4):285-90. PubMed ID: 18656338
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
    Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ
    Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells.
    Chen CH; Huang TS; Wong CH; Hong CL; Tsai YH; Liang CC; Lu FJ; Chang WH
    Food Chem Toxicol; 2009 Mar; 47(3):638-44. PubMed ID: 19150384
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
    Nagahara T; Okano J; Murawaki Y
    Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of C6 rat glioma proliferation by [Ru2Cl(Ibp)4] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential.
    Benadiba M; Dos Santos RR; Silva Dde O; Colquhoun A
    J Inorg Biochem; 2010 Sep; 104(9):928-35. PubMed ID: 20605638
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners.
    Iwanaga R; Komori H; Ishida S; Okamura N; Nakayama K; Nakayama KI; Ohtani K
    Oncogene; 2006 Mar; 25(12):1786-98. PubMed ID: 16288221
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of rosiglitazone on cells cycle, apoptosis and expression of Skp2 and p27Kip1 in hepatocellular carcinoma cell line].
    Peng L; Xu Z; Zhou Y; Yang T; Liang ZQ; Zhang M
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):148-9. PubMed ID: 20196958
    [No Abstract]   [Full Text] [Related]  

  • 79. [Effect of brain-derived neurotrophic factor on in vitro metastasis of hepatocellular carcinoma cell line HepG2].
    Xiao ZY; Wang YD; Chen XP
    Ai Zheng; 2006 Mar; 25(3):287-91. PubMed ID: 16536980
    [TBL] [Abstract][Full Text] [Related]  

  • 80. E2F-1 is a critical modulator of cellular senescence in human cancer.
    Park C; Lee I; Kang WK
    Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.